Tvardi Therapeutics Inc (TVRD)

Jan 16, 2026

Tvardi Therapeutics, Inc. Updates on Clinical Trials and Pipeline Progress - TradingView — Track All Markets

Jan 16, 2026

Jan 11, 2026

Tvardi Therapeutics, Inc. (NASDAQ:TVRD) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jan 11, 2026

Jan 10, 2026

Why retail investors favor Tvardi Therapeutics Inc. stockQuarterly Growth Report & Low Volatility Stock Suggestions - Улправда

Jan 10, 2026

Jan 10, 2026

Will Tvardi Therapeutics Inc. (69C) stock gain from green policies2025 Technical Patterns & Expert Approved Trade Ideas - Улправда

Jan 10, 2026

Jan 09, 2026

Tvardi reports improved fibrosis scores with TTI-101 in IPF trial - Investing.com Nigeria

Jan 09, 2026

Jan 08, 2026

Will Tvardi Therapeutics Inc. stock split attract more investorsWeekly Gains Summary & Technical Buy Zone Confirmation - Улправда

Jan 08, 2026

Jan 08, 2026

Can Tvardi Therapeutics Inc. stock outperform in 2025 bull market2025 Support & Resistance & Low Volatility Stock Suggestions - Улправда

Jan 08, 2026

Jan 08, 2026

Will Tvardi Therapeutics Inc. stock recover faster than peersPortfolio Performance Report & Free Technical Confirmation Trade Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Can Tvardi Therapeutics Inc. (69C) stock stage a strong rebound this quarterWeekly Investment Report & Weekly High Return Forecasts - Улправда

Jan 08, 2026

Jan 08, 2026

Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2026

Jan 08, 2026

Risk Analysis: Will Tvardi Therapeutics Inc. stock split attract more investorsInflation Watch & Real-Time Stock Movement Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Why Tvardi Therapeutics Inc stock is seen as undervaluedWeekly Risk Summary & Free Fast Gain Swing Trade Alerts - moha.gov.vn

Jan 08, 2026

Jan 08, 2026

Tvardi Therapeutics TTI-101 shows 9.4% fibrosis score decrease versus 2.4% placebo - marketscreener.com

Jan 08, 2026

Jan 08, 2026

Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights - The Manila Times

Jan 08, 2026

Jan 07, 2026

MSN Money - MSN

Jan 07, 2026

Jan 07, 2026

Street Watch: Can Tvardi Therapeutics Inc stock outperform in 2025 bull marketWeekly Risk Report & Safe Capital Investment Plans - Bộ Nội Vụ

Jan 07, 2026

Jan 06, 2026

Tvardi Therapeutics (NASDAQ:TVRD) Upgraded at Wall Street Zen - Defense World

Jan 06, 2026

Jan 04, 2026

Will Q4 Earnings Be a Catalyst for Cubex Tubings LimitedEconomic Data Impact & Free Hedging Tactics for Volatile Markets - earlytimes.in

Jan 04, 2026

Jan 02, 2026

Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today? - MSN

Jan 02, 2026

Dec 31, 2025

Tvardi Therapeutics, Inc. (TVRD) Total Expenses (TTM) - Zacks Investment Research

Dec 31, 2025

Dec 31, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Dec 31, 2025

Dec 30, 2025

What drives Tvardi Therapeutics Inc. (69C) stock priceEarnings Volatility Patterns & Capitalize On Momentum - earlytimes.in

Dec 30, 2025

Dec 29, 2025

Tvardi Therapeutics (NASDAQ:TVRD) Stock Rating Lowered by Wall Street Zen - Defense World

Dec 29, 2025

Dec 28, 2025

What drives Tvardi Therapeutics Inc 69C stock priceLarge Cap Stability Picks & Low Cost Stock Ideas - earlytimes.in

Dec 28, 2025

Dec 27, 2025

INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - TMX Newsfile

Dec 27, 2025

Dec 26, 2025

Pittsburgh Post-GazetteTvardi Therapeutics, Inc.Common Stock (Nasdaq:TVRD) Stock Quote - FinancialContent

Dec 26, 2025

Dec 24, 2025

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - FinancialContent

Dec 24, 2025

Dec 23, 2025

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GuruFocus

Dec 23, 2025

Dec 21, 2025

Tvardi Therapeutics (NASDAQ:TVRD) Rating Increased to Hold at Wall Street Zen - Defense World

Dec 21, 2025

Dec 20, 2025

SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire

Dec 20, 2025

Dec 19, 2025

Can Tvardi Therapeutics Inc. stock sustain market leadershipPortfolio Value Summary & Low Risk High Win Rate Picks - Bölüm Sonu Canavarı

Dec 19, 2025

Dec 18, 2025

Will Tvardi Therapeutics Inc. stock see insider buyingIPO Watch & Weekly Market Pulse Updates - Улправда

Dec 18, 2025

Dec 18, 2025

Tvardi Therapeutics grants retention stock options and adopts new severance plan - Investing.com Nigeria

Dec 18, 2025

Dec 17, 2025

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus

Dec 17, 2025

Dec 15, 2025

Tvardi Therapeutics Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

What analysts say about Tvardi Therapeutics Inc stockCash Flow Trends & Affordable Portfolio Growth - earlytimes.in

Dec 13, 2025

Dec 12, 2025

Tvardi Therapeutics Advances STAT3 Inhibitor Clinical Trials - MSN

Dec 12, 2025

Dec 09, 2025

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - TMX Newsfile

Dec 09, 2025

Dec 07, 2025

Tvardi Therapeutics (TVRD) Price Target Decreased by 24.64% to 15.15 - MSN

Dec 07, 2025

Dec 07, 2025

How Low Can Tvardi Therapeutics Stock Really Go? - Trefis

Dec 07, 2025